SCHEMBL6285875

SCHEMBL6285875

N#Cc1cccc(-c2nc(Cl)sc2C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
ALDH1A1 P00352 1/20 0.47
F11 P03951 1/20 0.46
PIN1 Q13526 1/20 0.46
XDH P47989 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
NPSR1 Q6W5P4 3/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ADORA2A P29274 4/20 0.45
ADORA1 P30542 3/20 0.45
PDE4A P27815 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
EIF4E P06730 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287392 0.84 F11 (0.52) FNTAFNTBF11PIN1XDH
SCHEMBL6288115 0.82 FNTA (0.54) FNTAFNTBALDH1A1
SCHEMBL3894571 0.80 ALDH1A1 (0.68) ALDH1A1NPSR1LMNASMN1; SMN2ADORA2A
SCHEMBL8231726 0.77 XDH (0.50) FNTAFNTBF11PIN1XDH
SCHEMBL8236352 0.77 XDH (0.44) FNTAFNTBF11PIN1XDH
SCHEMBL8236048 0.77 XDH (0.44) FNTAFNTBF11PIN1XDH
SCHEMBL11292190 0.76 ALDH1A1 (0.58) ALDH1A1PIN1XDHNPSR1LMNA
SCHEMBL25779068 0.76 FNTA (0.49) FNTAFNTBF11PIN1XDH
SCHEMBL25213476 0.73 PDE4A (0.47) F11PIN1XDHSLC22A12ADORA2A
SCHEMBL175512 0.73 RORB (0.54) ALDH1A1ADORA2AADORA1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962935-B2 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-20040073029-A1 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors PRUITT JAMES RUSSELL (US) 2004-04-15 US disclosed
US-6569874-B1 Such as 2-acetylamino-4-(3-amidinophenyl)-5-((2'-amino-sulfonyl-(1,1')-biphen-4 -yl)aminocarbonyl)thiazole; for treatment of thromboembolic disorders BRISTOL-MYERS SQUIBB COMPANY 2003-05-27 US disclosed
EP-0946528-B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-04-09 EP disclosed
US-6187797-B1 ANTICOAGULANTS; TRYPSINE-LIKE SERINE PROTEASE INHIBITORS DUPONT PHARMACEUTICALS COMPANY 2001-02-13 US disclosed
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073029-A1 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors F12, XDH, F2 FNTA 3536/4885FNTB 1556/4885ALDH1A1 596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.